GVEYX
Price
$18.79
Change
-$0.01 (-0.05%)
Updated
Jun 5 closing price
Net Assets
976.74M
RMEBX
Price
$57.64
Change
-$0.04 (-0.07%)
Updated
Jun 5 closing price
Net Assets
105.31B
Interact to see
Advertisement

GVEYX vs RMEBX

Header iconGVEYX vs RMEBX Comparison
Open Charts GVEYX vs RMEBXBanner chart's image
GuideStone Funds Value Equity Instl
Price$18.79
Change-$0.01 (-0.05%)
VolumeN/A
Net Assets976.74M
American Funds American Mutual R2E
Price$57.64
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets105.31B
GVEYX vs RMEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVEYX vs. RMEBX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVEYX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 105B vs. GVEYX (977M). GVEYX pays higher dividends than RMEBX: GVEYX (1.42) vs RMEBX (1.16). GVEYX was incepted earlier than RMEBX: GVEYX (24 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than GVEYX (0.63). GVEYX is a more actively managed with annual turnover of: 62.00 vs. RMEBX (31.00). RMEBX has a lower initial minimum investment than GVEYX: RMEBX (250) vs GVEYX (1000000). RMEBX annual gain was more profitable for investors over the last year : 8.30 vs. GVEYX (-1.00). RMEBX return over 5 years is better than : 49.85 vs. GVEYX (15.95).
GVEYXRMEBXGVEYX / RMEBX
Total Expense Ratio0.631.0759%
Annual Report Gross Expense Ratio0.631.0759%
Fund Existence24 years11 years-
Gain YTD0.1605.3493%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets977M105B1%
Annual Yield % from dividends1.421.16123%
Returns for 1 year-1.008.30-12%
Returns for 3 years-4.8917.96-27%
Returns for 5 years15.9549.8532%
Returns for 10 years-7.8068.21-11%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERV5.720.43
+8.22%
Verve Therapeutics
VRNT18.780.97
+5.45%
Verint Systems
CHRS0.80N/A
+0.48%
Coherus Oncology Inc
CHSCN25.15-0.05
-0.20%
CHS
PRI265.13-2.99
-1.12%
PRIMERICA